Bristol-Myers Squibb Company
BMY
$60.66
$0.360.60%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.05B | 6.04B | 5.05B | 5.42B | -8.95B |
| Total Depreciation and Amortization | 4.08B | 4.90B | 6.50B | 8.09B | 9.58B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.48B | 3.21B | 3.23B | 2.06B | 13.75B |
| Change in Net Operating Assets | -455.00M | 2.48B | 1.13B | -1.26B | 810.00M |
| Cash from Operations | 14.16B | 16.62B | 15.90B | 14.31B | 15.19B |
| Capital Expenditure | -1.31B | -1.32B | -1.32B | -1.22B | -1.25B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -3.94B | -2.28B | -758.00M | -1.85B | -21.82B |
| Divestitures | 1.07B | 1.13B | 1.10B | 1.10B | 1.10B |
| Other Investing Activities | 52.00M | -392.00M | -407.00M | -264.00M | 618.00M |
| Cash from Investing | -4.13B | -2.87B | -1.39B | -2.23B | -21.35B |
| Total Debt Issued | 5.77B | 26.00M | 116.00M | 384.00M | 15.97B |
| Total Debt Repaid | -10.94B | -872.00M | -3.39B | -5.87B | -5.87B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.05B | -5.00B | -4.95B | -4.91B | -4.86B |
| Other Financing Activities | -128.00M | -114.00M | -95.00M | -112.00M | -106.00M |
| Cash from Financing | -10.35B | -5.96B | -8.32B | -10.51B | 5.13B |
| Foreign Exchange rate Adjustments | 195.00M | 43.00M | 124.00M | -26.00M | -137.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -129.00M | 7.83B | 6.32B | 1.54B | -1.17B |